SCHEMBL15062696

SCHEMBL15062696

[2H]C([2H])[Si](C)(OCc1ccc(C#C)cc1)C(C)(C)C

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3020098 0.91 HDAC8 (0.34) HDAC8
SCHEMBL8754149 0.77 HDAC8 (0.37) HDAC8
SCHEMBL20487117 0.75 DUT (0.34) HDAC8
SCHEMBL29466876 0.74 HMGCR (0.33)
SCHEMBL8812553 0.74 CYP2A6 (0.46)
SCHEMBL15062712 0.73 CYP1A1 (0.35)
SCHEMBL3008315 0.72 GABRA1 (0.30)
SCHEMBL15320670 0.72 HRH3 (0.30)
SCHEMBL6885043 0.71 BACE1 (0.33)
SCHEMBL19131754 0.70 ALDH1A1 (0.34) HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8809012-B2 Labeling agent and methods for simultaneous sequencing and quantification of multiple peptides and proteins using the same Postach Academy-Industry Foundation (KR) 2014-08-19 US disclosed
US-20130183704-A1 Labeling Agent and Methods for Simultaneous Sequencing and Quantification of Multiple Peptides and Proteins Using the Same POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) 2013-07-18 US disclosed
EP-2610243-A2 LABELING AGENT AND AMINO ACID SEQUENCE USING SAME, AND METHOD FOR PERFORMING SIMULTANEOUS QUANTITATIVE ANALYSIS OF MULTIPLE PROTEINS Postech Academy-industry Foundation (KR) 2013-07-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130183704-A1 Labeling Agent and Methods for Simultaneous Sequencing and Quantification of Multiple Peptides and Proteins Using the Same YWHAQ, IAPP, RPS27A HDAC8 3273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.